Traditional first line therapy for glaucoma treatment has historically been topical glaucoma medications, but with new studies supporting selective laser trabeculoplasty and the recent addition of glaucoma drug delivery to the market the debate has begun. This course will include three instructors, each taking a side, and debating the current literature on topical glaucoma medications vs SLT vs glaucoma drug delivery as first line therapy for our glaucoma patients.

Course Code:



Justin Schweitzer, O.D.

Walter Whitley, O.D.

Nathan Lighthizer, O.D.



AOA Expiration Date:


Related News

Constant presence: Alliance builds reputation for patient safety advocacy

Founded five years ago, the Health Care Alliance for Patient Safety (HCAPS) is making good on its mission to advocate for patient safety and protect the fundamental doctor-patient relationship. The alliance’s advocacy will be recognized with the AOA’s Apollo Award during a ceremony at the 2023 Optometry’s Meeting® June 21-24.

What defines the value of care we provide?

Health and vision plans have not adapted and grown with the care we deliver but hold back optometry’s momentum.

How to speak the universal language of care

How to create a bilingual and culturally sensitive practice, why it matters to patients and how it can set you apart from the competition.